Myocardial ischemia-reperfusion injury is a common condition in cardiovascular diseases,
and the mechanism of its occurrence involves multiple complex metabolic pathways and …

Hyperlipidaemia is a well‐established risk factor for cardiovascular diseases and therefore,
many animal model have been developed to mimic the human abnormal elevation of blood …

Background. Myocardial ischemia/reperfusion (MI/R) injury is a common pathology in
ischemia heart disease. Long noncoding RNAs (lncRNAs) are significant regulators related …

Myocardial infarction (MI) is one of the leading causes of deaths globally. The early
diagnosis of MI lowers the rate of subsequent complications and maximizes the benefits of …

Acute myocardial infarction (AMI) causes many deaths around the world. Early diagnosis
can prevent the development of AMI and provide theoretical support for the subsequent …

Background Myocardial ischemia/reperfusion (I/R) injury is a fatal event that usually occurs
after reperfusion therapy for myocardial infarction. Dexmedetomidine (Dex) has been shown …

Simple Summary High-density lipoproteins are often described as the 'good'cholesterol in
the bloodstream, as this complex of lipids (fats) and proteins is known to protect many cells …

Abstract Sirtuin1 (Sirt1) activation significantly attenuated calcium oxalate (CaOx) crystal
deposition and renal inflammatory injury by regulating renal immune microenvironment …

Background Myocardial ischemia–reperfusion injury (MIRI) caused by the reperfusion
therapy of myocardial ischemic diseases is a kind of major disease that threatens human …

Cardioprotection includes all mechanisms that contribute to preservation of the heart by
reducing or even preventing myocardial damage. High-density lipoproteins (HDLs) are …